COMP <GO>
TNMG vs HAO // EV/EBITDA & P/E VALUATION
TNL Mediagene (NASDAQ) VS. Haoxi Health Technology Limited (Class A) (NASDAQ) • 15-METRIC TALLY: TNMG 2
— HAO 0
■ METRIC PARITY
LAST: $3.05 (+0.99%) • MKT CAP: $2.3M
valuation
—
LAST: $2.04 (+0.99%) • MKT CAP: $1.3M
valuation
—
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (TNMG VS. HAO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | TNMG | HAO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | — | 96.00% | — | TIE | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | — | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation ACTIVE | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin | — | -60.00% | — | TIE | /operating-margins <GO> |
| Net Profit Margin | — | 68.00% | — | TIE | /net-margins <GO> |
| Revenue Growth (YoY) | — | -54.60% | — | TIE | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | — | 3/9 | — | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 57.0 | 34.0 | +22.98 | TNMG | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.3M | $1.3M | $1.0M | TNMG | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | TNMG REV | HAO REV | TNMG GROSS % | HAO GROSS % | TNMG FCF | HAO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | — | $537.6K | — | 98.0% | — | -$3.4M |
| FY 2024 | — | $1.2M | — | 98.0% | — | -$802.9K |
| FY 2023 | — | $28.2M | — | — | — | -$872.1K |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
TNMG // BETA —
HAO // BETA —